Omalizumab: An update on efficacy and safety in moderate-to-severe allergic asthma

By Chipps Bradley E.   Figliomeni Maria   Spector Sheldon  

Allergy and Asthma Proceedings, Vol. 33, Iss. 5, 2012-09 ,pp. : 377-385

OceanSide Publications, Inc

Access to resources Recommend Favorite

Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma

By Massanari Marc   Kianifard Farid   Zeldin Robert K.   Geba Gregory P.  

Allergy and Asthma Proceedings, Vol. 30, Iss. 5, 2009-09 ,pp. : 534-539

OceanSide Publications, Inc

Access to resources Recommend Favorite

Clinical efficacy of omalizumab in an elderly veteran population with severe asthma

By Verma Prashant   Randhawa Inderpal   Klaustermeyer William B.  

Allergy and Asthma Proceedings, Vol. 32, Iss. 5, 2011-09 ,pp. : 346-350

OceanSide Publications, Inc

Access to resources Recommend Favorite

Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: One center's experience with 14 cases

By  

Allergy and Asthma Proceedings, Vol. 36, Iss. 6, 2015-11 ,pp. : 493-500

OceanSide Publications, Inc

Access to resources Recommend Favorite

Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: A 6-year pragmatic data review

By Storms William   Bowdish Matthew S.   Farrar Judith R.  

Allergy and Asthma Proceedings, Vol. 33, Iss. 2, 2012-03 ,pp. : 172-177

OceanSide Publications, Inc

Access to resources Recommend Favorite